actobacillus Reuteri for treatment of children with abdominal pai

Not Applicable

• Conditions: Abdominal Pain.; Other and unspecified abdominal pain

• Registration Number: IRCT2014083018971N1
• Lead Sponsor: Zanjan University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Inclusion criteria include: All children aged 4 to 16 years with functional abdominal pain (FAP) according to Rome III diagnostic criteria
Exclusion criteria include: Have an abdominal pain with known organic cause; history of abdominal and gastrointestinal surgery; FTT or weight loss more than 5% of body weight; any abnormal paraclinical evaluations and history of drug use in the past 3 months (including antidepressants or laxatives).

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of abdominal pain. Timepoint: Baseline, one month after starting treatment and one month after discontinuing the drugs. Method of measurement: numbers of pain episode per month recorded.;Intensityof abdominal pain. Timepoint: Baseline, one month after starting treatment and one month after discontinuation of the treatment. Method of measurement: Pain intensity was assessed according to the Wong-Baker faces scale systems.

Secondary Outcome Measures

Name	Time	Method
Assoiated Sign. Timepoint: Baseline, one month after starting treatment and one month after discontinuing the drugs. Method of measurement: Based on history and clinical examination.;Side Effects and complication. Timepoint: Baseline, one month after starting treatment and one month after discontinuing the drugs. Method of measurement: Based on history and clinical examination.